Also Macquarie
ResMed Inc. (RMD AU)Taking a breatherKey points RMD’s 2Q19 result was below our forecasts, with revised cost guidanceahead of expectations. Americas growth remains robust, but with a moderation in RoW devicesgrowth anticipated over the balance of FY19. We see medium-longer term opportunities from SaaS acquisitions, but nearterm risks for the core sleep business. Retain an Underperform rating.
Steady Decline, page-17
Add RWC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.88 |
Change
-0.080(1.61%) |
Mkt cap ! $3.832B | |||
| Open | High | Low | Value | Volume |
| $4.83 | $4.89 | $4.80 | $12.31M | 2.534M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2545 | $4.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.88 | 54361 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RWC (ASX) Chart |